Aug. 13, 2025
9th Circuit revives trade secrets in Quintara biotech lawsuit
The 9th Circuit revived nine trade secret claims in a biotech suit, ruling a federal judge wrongly applied California law to dismiss them before discovery under the Defend Trade Secrets Act.
A 9th U.S. Circuit Court of Appeals panel on Tuesday found a federal judge in San Francisco improperly struck most of a plaintiff DNA company's alleged trade secrets at the outset of the case's discovery phase.
The opinion answers the question of how much a trade secrets plaintiff must disclose to satisfy "sufficient particularity" and at what stage.
According to the Defend Trade Secrets Act (DTSA), the federal law does not require a plaintiff to prove t...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In